author-photo

Matej Ondrus

6

Papers

256

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

2021
Show All
- Source
- Cite
- Save
Citations (7)
AADvac1, an Active Immunotherapy for Alzheimer’s Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development

2018
Show All
- Source
- Cite
- Save
Citations (24)
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

2017 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (162)
CHARACTERISATION OF THE ANTIBODY RESPONSE TO AADVAC1: THE FIRST-IN-KIND ACTIVE VACCINE AGAINST NEUROFIBRILLARY TAU PATHOLOGY

2016 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (2)